Lyka Labs Ltd.
| BSE: 500259 | Sector: Health care |
| NSE: LYKALABS | ISIN Code: INE933A01014 |
| BSE 00:00 | 16 Sep | 86.85 |
2.00 (2.36%) |
OPEN
85.90 |
HIGH
89.05 |
LOW
80.65 |
| NSE 00:00 | 16 Sep | 86.75 |
1.85 (2.18%) |
OPEN
85.40 |
HIGH
89.10 |
LOW
80.70 |
| OPEN | 85.90 |
| PREVIOUS CLOSE | 84.85 |
| VOLUME | 57725 |
| 52-Week high | 102.70 |
| 52-Week low | 16.10 |
| P/E | 20.10 |
| Mkt Cap.(Rs cr) | 249 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Lyka Labs Ltd. (LYKALABS) - Net Profit
Net Profit
| COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Profit (Rs crore) |
| Aurobindo Pharma | 754.50 | -4.25 | -0.56 | 3112.91 |
| Cipla | 954.00 | 0.25 | 0.03 | 2468.28 |
| Dr Reddy's Labs | 4931.70 | -33.30 | -0.67 | 2186.40 |
| Sun Pharma.Inds. | 780.85 | 0.60 | 0.08 | 2139.70 |
| Divi's Lab. | 5163.80 | 6.30 | 0.12 | 1954.72 |
| Alkem Lab | 3868.75 | 17.15 | 0.45 | 1685.08 |
| Glenmark Pharma. | 535.25 | -0.35 | -0.07 | 1649.45 |
| Cadila Health. | 564.25 | -1.70 | -0.30 | 1476.20 |
| Lupin | 967.70 | -22.10 | -2.23 | 1258.62 |
| Alembic Pharma | 783.20 | -6.30 | -0.80 | 1175.39 |
| Ipca Labs. | 2569.90 | -56.25 | -2.14 | 1140.77 |
| Torrent Pharma. | 3111.75 | -11.35 | -0.36 | 1137.85 |
| Gland Pharma | 4036.80 | 19.50 | 0.49 | 997.01 |
| Laurus Labs | 649.85 | -12.75 | -1.92 | 956.11 |
| Abbott India | 20989.65 | -132.60 | -0.63 | 690.69 |
| Ajanta Pharma | 2186.35 | -32.50 | -1.46 | 675.64 |
| Wockhardt | 439.40 | -6.20 | -1.39 | 593.29 |
| Granules India | 332.95 | -0.65 | -0.19 | 552.78 |
| Pfizer | 6020.90 | 20.25 | 0.34 | 497.61 |
| Sanofi India | 8033.50 | -82.15 | -1.01 | 477.60 |
Quick Links for Lyka Labs:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
